Boiron : Q1 2020 sales above expectations, thanks to the international segment (+40%) – limited downside – reorganisation effects will not be visible in the short term
>Q1 better than expected (+9%) - In Q1, sales (€ 156.6m, +9.3% and 8.8% at cc) stood out above our expectations, due to international markets (+40%): sales in North America increased by 70.8%, favoured by a base effect (Q1 2019: -20%) and European countries recorded growth of 18%.Moreover, Boiron confirmed that it has postponed the opening of discussions on the reorganisation project (announced in early 2020 / exceptional PSE: > 530 jobs lost and 12 distribution ...Boiron manufactures and markets homeopathic medicines. Homeopathic medicines are prepared from vegetable, animal, mineral, or chemical substances, which are diluted. Co. sells three types of products in 59 countries: Non-proprietary homeopathic medicines, OTC family medication specialties, and Other products. There are two large families of homeopathic medicines: Those associated with precise therapeutic indications and dosage, and those that do not mention a therapeutic indication or dosage. Co. supports homeopathy education and training organizations for healthcare professionals. Some of Co.'s brand names include Oscillococcinum®, Stodal®, S?datif PC®, and Coryzalia.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.